Loading clinical trials...
Loading clinical trials...
The purpose of this study is to provide anidulafungin and voriconazole to healthy subjects to determine the drug concentration in the lung.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT05421858 · Candidemia, Candidiasis, Invasive
NCT03748069 · Influenza With Pneumonia, Invasive Pulmonary Aspergillosis
NCT06244979 · Pulmonary Aspergillosis, Chronic Pulmonary Aspergillosis, and more
NCT06537726 · Leukemia, Leukemia, Myeloid, and more
NCT03717623 · Posaconazole, Pharmacokinetics, and more
Pfizer Investigational Site
Hartford, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions